2021 Scientific Sessions

Structural Heart Disease

Abstract Session I: Structural Heart Disease
Assessment of Bioprosthetic Valve Remodeling with Fracture procedure in Valve-in-Valve TAVR by Computed Tomography Angiography
Go Hashimoto
Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-analysis.
Nischit Baral, MBBS
Procedural Safety and Outcomes of Watchman vs. Amulet: A Meta-Analysis of Observational Studies
Arslan Ahmed, MD
Mid-Term Outcomes Following Implantation of Watchman or Amulet: A Meta-Analysis of Observational Studies
Arav Jhand, MBBS
Percutaneous mitral balloon comissurotomy in Tunisian pregnant women: A monocentric cohort study
Ouday Benabdeljelil, PhD
Early Insights into Trends and Predictors of the Next Day Discharge Approach After Transcatheter Mitral Valve Repair Procedures
Jelani K Grant, MD
In-Hospital Outcomes of Patients With Paroxysmal versus Persistent Atrial Fibrillation Undergoing Percutaneous Mitral Valve Repair
Genaro Velazquez, MD
Valve in valve Trancatheter Mitral Valve Replacement (ViV TMVR) vs. Redo Surgical Mitral Valve Replacement (SMVR) for degenerating bioprosthetic valves- A Meta-Analysis
Salman Zahid
Abstract Session J: Structural Heart Disease - TAVR
Characteristics and outcomes of patients undergoing sequential Transcatheter Edge-to-edge Mitral Valve Repair and Transcatheter aortic valve replacement: A single center experience.
Hassaan B Arshad, MD
Comparison of Catheterization Versus Echocardiographic Based Gradients in Balloon Expandable Versus Self Expanding TAVR
Michael A Biersmith, MD
The Effect SARS-COV-2 on Cases of TAVR
Sahil Dave
30-Days readmission after TAVR in patients with cancer: Outcomes and predictors.
Juan Del Cid Fratti MD MS, MD MSc
SHORT-TERM OUTCOMES AFTER TAVR IN PATIENTS WITH LOCAL AND ADVANCED MALIGNANCY: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2016-2017.
Juan Del Cid Fratti MD MS, MD MSc
Peripheral Artery Disease and the Risk of Vascular Access Complications in Patients Undergoing Transfemoral TAVR: Insights from the Duke CT TAVR Registry
Sebastian Estrada, MD
"The Effect Of The Dyevert Plus Contrast Reduction System On Cases Of Transcatheter Aortic Valve Replacement (TAVR)
Ali Farooq, M.D
An Optimized TAVR care pathway using Evolut PRO and PRO+: Early results from the Optimize PRO study
Kendra J. Grubb, M.D.
Changes in Mitral Regurgitation Severity Post Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis
Kris Kumar, DO, MSc
Long-Term Outcomes Following Transcatheter Aortic Valve Replacement as Stratified by Antiplatelet and Anticoagulation Strategy
Kris Kumar, DO, MSc
Impact of Prosthetic Valve Endocarditis on Low Risk Undergoing Transcatheter Aortic Valve Replacement
Dr. Giorgio A. Medranda, MD, FSCAI
Single Center Experience with the LOTUS Edge Transcatheter Heart Valve
Dr. Giorgio A. Medranda, MD, FSCAI
Impact of anemia on short-term outcomes after TAVR: Subgroup analysis from the BRAVO-3 randomized control trial
Victor Yamada Razuk, MD
Thirty-day outcomes of Left Ventricular Pacing during Transcatheter aortic valve implantation: A Systematic review and meta-Analysis
Rosa Natalia Cruz Torres, MD
Chronic Kidney Disease and Outcomes after Transcatheter Aortic Valve Replacement
Aamir Twing, MD
Use of Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement, From National Inpatient Sample
Salman Zahid
Redo Transcatheter Valve in Valve Versus Redo Surgical Aortic Valve Replacement, from National Inpatient Sample
Salman Zahid
In-Hospital Outcomes of Transcatheter Aortic Valve Replacement with Hyponatremia - A Propensity Matched Analysis.
Mohamed Zghouzi, MD
Advanced Cardiac Imaging
Advanced Concepts in TAVR: Cusp Overlap Techniques in Complex Anatomies
Advanced Topics in ASD/PFO and LAA Closure: Optimizing Your Skill Sets
TEE vs ICE in LAAC
Mukta C. Srivastava, M.D.
LAAC Step by Step: Cutting Edge Devices
Jacqueline Saw, M.D., FSCAI
Device Embolization: How to Avoid/How to Retrieve
David T. Balzer, M.D., MSCAI
Special Cases in PFO Closure: Managing Afib and Hypercoagulable Patients
Dr. Andrew Michael Goldsweig, MD, MS, FSCAI
PFOs: Indications Beyond Stroke Prevention
Dr. Andrew Michael Goldsweig, MD, MS, FSCAI
Best of Structural Complex Cases
Transcatheter Aortic Valve Implantation During Pregnancy
Pavan Thaneeru, MBBS
Transcatheter Pulmonic Valve-in-Homograft Replacement in a Patient with Carcinoid Heart Disease
Rahul Sawhney, DO
Percutaneous Mitral Valve Repair in Patient with Cardiogenic Shock Requiring Mechanical Circulatory Support.
Islam Shatla, MD
TRANSCATHETER CORRECTION OF SUPERIOR SINUS VENOSUS ATRIAL SEPTAL DEFECT(SVC ASD) WITH PPARTIAL ANAMOLOUS PULMONARY VENOUS DRAINAGE(PAPVC) USING AORTIC STENT GRAFT
Radhapriya Yalamanchi, MBBS, DNB Cardiology
Explantation of an Implantable Left Ventricular Assist Device following Successful Percutaneous Repair of Severe Degenerative Mitral regurgitation
Junaid Mir, MD
Severe mitral regurgitation in the setting of prior surgical mitral valve repair with Alfieri stitch treated with a vascular plug and a MitraClip
Katherine Rajotte, PA
Lacerating the barricade: A challenging case of TAVR/TMVR with concomitant LAMPOON and BASILICA procedures
Kirtivardhan Vashistha, M.D.
Controversies in Severe Aortic Stenosis
Fixing a Hole
Growing a Structural Program: Hot Topics in Structural Heart Disease
Hemodynamic Brain Teasers
LAA/PFO: Stroke Prevention in Interventional Cardiology
Mitral Fundamentals: Repair and Replacement
Mitral Valve Repair
Mitral Valve Replacement
Reduction of Recurrent Strokes in Patients with PFO: Long-Term Outcomes
SCAI Women in Innovations (SCAI-WIN): Structural Heart Disease and Interventions
TAVR Fundamentals
TAVR Fundamentals: Tips and Tricks
Tricuspid Valve Repair and Replacement